These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26493311)

  • 61. Inhibition of TRPC1 prevents cardiac hypertrophy via NF-κB signaling pathway in human pluripotent stem cell-derived cardiomyocytes.
    Tang L; Yao F; Wang H; Wang X; Shen J; Dai B; Wu H; Zhou D; Guo F; Wang J; Li T; Wang H; Gong T; Su J; Wang L; Liang P
    J Mol Cell Cardiol; 2019 Jan; 126():143-154. PubMed ID: 30423318
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fluconazole Represses Cytochrome P450 1B1 and Its Associated Arachidonic Acid Metabolites in the Heart and Protects Against Angiotensin II-Induced Cardiac Hypertrophy.
    Alammari AH; Shoieb SM; Maayah ZH; El-Kadi AOS
    J Pharm Sci; 2020 Jul; 109(7):2321-2335. PubMed ID: 32240690
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Novel Protective Role of Myeloid Differentiation 1 in Pathological Cardiac Remodelling.
    Xiong X; Liu Y; Mei Y; Peng J; Wang Z; Kong B; Zhong P; Xiong L; Quan D; Li Q; Wang G; Huang H
    Sci Rep; 2017 Feb; 7():41857. PubMed ID: 28165494
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of inflammation on cytochrome P450-mediated arachidonic acid metabolism and the consequences on cardiac hypertrophy.
    ElKhatib MAW; Isse FA; El-Kadi AOS
    Drug Metab Rev; 2023; 55(1-2):50-74. PubMed ID: 36573379
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The cardiac translational landscape reveals that micropeptides are new players involved in cardiomyocyte hypertrophy.
    Yan Y; Tang R; Li B; Cheng L; Ye S; Yang T; Han YC; Liu C; Dong Y; Qu LH; Lui KO; Yang JH; Huang ZP
    Mol Ther; 2021 Jul; 29(7):2253-2267. PubMed ID: 33677093
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cardioprotective Effects of the GRK2 Inhibitor Paroxetine on Isoproterenol-Induced Cardiac Remodeling by Modulating NF-κB Mediated Prohypertrophic and Profibrotic Gene Expression.
    Alonazi AS; Bin Dayel AF; Albuaijan DA; Bin Osfur AS; Hakami FM; Alzayed SS; Almotairi AR; Khan MR; Alharbi HM; Ali RA; Alamin MA; Alghibiwi HK; Alrasheed NM; Alhosaini KA
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139099
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Rosiglitazone promotes cardiac hypertrophy and alters chromatin remodeling in isolated cardiomyocytes.
    Pharaon LF; El-Orabi NF; Kunhi M; Al Yacoub N; Awad SM; Poizat C
    Toxicol Lett; 2017 Oct; 280():151-158. PubMed ID: 28822817
    [TBL] [Abstract][Full Text] [Related]  

  • 68. REDD1 attenuates cardiac hypertrophy via enhancing autophagy.
    Liu C; Xue R; Wu D; Wu L; Chen C; Tan W; Chen Y; Dong Y
    Biochem Biophys Res Commun; 2014 Nov; 454(1):215-20. PubMed ID: 25450383
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Scutellarein protects against cardiac hypertrophy via suppressing TRAF2/NF-κB signaling pathway.
    Shi X; Hu Y; Jiang Y; Wu J; Zhang C; Zhang J; Wu S; Wu Y; Dong W; Li J
    Mol Biol Rep; 2022 Mar; 49(3):2085-2095. PubMed ID: 34988890
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pyrroloquinoline quinone attenuates isoproterenol hydrochloride‑induced cardiac hypertrophy in AC16 cells by inhibiting the NF‑κB signaling pathway.
    Wen J; Shen J; Zhou Y; Zhao X; Dai Z; Jin Y
    Int J Mol Med; 2020 Mar; 45(3):873-885. PubMed ID: 31922230
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Heme oxygenase-1 inhibits pro-oxidant induced hypertrophy in HL-1 cardiomyocytes.
    Brunt KR; Tsuji MR; Lai JH; Kinobe RT; Durante W; Claycomb WC; Ward CA; Melo LG
    Exp Biol Med (Maywood); 2009 May; 234(5):582-94. PubMed ID: 19244544
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ameliorative Role of Fluconazole Against Abdominal Aortic Constriction-Induced Cardiac Hypertrophy in Rats.
    Shoieb SM; Alammari AH; Levasseur J; Silver H; Dyck JRB; El-Kadi AOS
    J Cardiovasc Pharmacol; 2022 Jun; 79(6):833-845. PubMed ID: 35266922
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Rapamycin attenuated cardiac hypertrophy induced by isoproterenol and maintained energy homeostasis via inhibiting NF-κB activation.
    Chen X; Zeng S; Zou J; Chen Y; Yue Z; Gao Y; Zhang L; Cao W; Liu P
    Mediators Inflamm; 2014; 2014():868753. PubMed ID: 25045214
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 12-HETE facilitates cell survival by activating the integrin-linked kinase/NF-κB pathway in ovarian cancer.
    Liu Q; Tan W; Che J; Yuan D; Zhang L; Sun Y; Yue X; Xiao L; Jin Y
    Cancer Manag Res; 2018; 10():5825-5838. PubMed ID: 30510451
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inhibition of cytochrome P450 epoxygenase promotes endothelium-to-mesenchymal transition and exacerbates doxorubicin-induced cardiovascular toxicity.
    Dhulkifle H; Therachiyil L; Hasan MH; Sayed TS; Younis SM; Korashy HM; Yalcin HC; Maayah ZH
    Mol Biol Rep; 2024 Jul; 51(1):859. PubMed ID: 39066934
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A Comprehensive Insight and Mechanistic Understanding of the Lipidomic Alterations Associated With DCM.
    Saha S; Singh P; Dutta A; Vaidya H; Negi PC; Sengupta S; Seth S; Basak T
    JACC Asia; 2023 Aug; 3(4):539-555. PubMed ID: 37614533
    [TBL] [Abstract][Full Text] [Related]  

  • 77. 16R-HETE and 16S-HETE alter human cytochrome P450 1B1 enzyme activity probably through an allosteric mechanism.
    Hidayat R; Shoieb SM; Mosa FES; Barakat K; Brocks DR; Isse FA; Gerges SH; El-Kadi AOS
    Mol Cell Biochem; 2024 Jun; 479(6):1379-1390. PubMed ID: 37436655
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mechanistic insights into the health benefits of fish-oil supplementation against fine particulate matter air pollution: a randomized controlled trial.
    Zhou L; Jiang Y; Lin Z; Chen R; Niu Y; Kan H
    Environ Health; 2022 Oct; 21(1):104. PubMed ID: 36309727
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Determination of Lipoxygenase, CYP450, and Non-Enzymatic Metabolites of Arachidonic Acid in Essential Hypertension and Type 2 Diabetes.
    Feugray G; Pereira T; Iacob M; Moreau-Grangé L; Prévost G; Brunel V; Joannidès R; Bellien J; Duflot T
    Metabolites; 2022 Sep; 12(9):. PubMed ID: 36144261
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cytotoxicity and Genotoxicity of Azobenzene-Based Polymeric Nanocarriers for Phototriggered Drug Release and Biomedical Applications.
    Londoño-Berrío M; Pérez-Buitrago S; Ortiz-Trujillo IC; Hoyos-Palacio LM; Orozco LY; López L; Zárate-Triviño DG; Capobianco JA; Mena-Giraldo P
    Polymers (Basel); 2022 Jul; 14(15):. PubMed ID: 35956634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.